Apollo astronauts at risk of cardiovascular death, finds study

Members of the successful Apollo space programme are experiencing higher rates of cardiovascular problems, thought to be caused by their exposure to deep space radiation, according to a new study.

Michael Delp from the Florida State University explains the men who travelled into deep space as part of the lunar missions were exposed to galactic cosmic radiation that have not been experienced by any other astronauts or cosmonauts. That exposure is now manifesting itself as cardiovascular problems. "We know very little about the effects of deep space radiation on human health, particularly on the cardiovascular system," Delp said. "This gives us the first glimpse into its adverse effects on humans," he said.

Delp's research is of special interest now as the US and other countries, as well as private organisations, make plans for deep space travel. NASA has unveiled plans for US orbital missions around the Moon from 2020 to 2030 in preparation for a manned flight to Mars. Russia, China and the European Space Agency are all looking at lunar missions. And SpaceX, owned by Elon Musk, has proposed landing humans on Mars by 2026.

As a group, astronauts are highly educated and have access to top medical care, meaning their health-care outcomes are largely better than the population in general.

However, the astronauts in the Apollo programme experienced different environmental conditions than anyone else in the world when they travelled into deep space.

Delp found that 43 per cent of the deceased astronauts died from a cardiovascular problem. That is four to five times higher than non-flight astronauts and those who have travelled in low Earth orbit. Of the 24 men who flew into deep space on the Apollo lunar missions, eight have died and seven were included in the study. Delp and his colleagues also exposed mice to the type of radiation that Apollo astronauts would have experienced. After six months -equivalent of 20 human years - the mice demonstrated an impairment of arteries that is known to lead to the development of atherosclerotic cardiovascular disease in humans.